Health

Enabling AI-driven health advances without sacrificing patient privacy

There’s a lot of excitement at the intersection of artificial intelligence and health care. AI has already been used to improve disease treatment and detecIon, discover promising new drugs, identify links between genes and diseases, and more. By analyzing large datasets and finding patterns, virtually any new algorithm has the potential to help patients — AI researchers just need access to the right data to train and test those algorithms.

Read the full story. 

View Project

Using digital health to improve health outcomes and equity

The pandemic’s disruptions create a moment to fundamentally rethink health care. Rather than simply replicating in-person care virtually, how can care be transformed to deliver dramatically better outcomes for patents? Digital health can be used to improve health care results and health equity by creating better solutions for people who face challenges in access and/or in achieving better health outcomes. For instance, by adding to the efficacy and efficiency of care delivery. Providing value-based care starts with identifying the shared needs and common goals of a group of people who are not well-served by today’s care.

Read the full story. 

View Project

Slideshow: “MC12” WTO Ministerial Conference

At the WTO’s Twelfth Ministerial Conference WTO Members should agree new trade rules to support the global response to COVID-19, accelerate the economic recovery, and enhance future pandemic preparedness. WTO Members should eliminate tariffs on health products, including finished therapeutics, diagnostics, and vaccines, as well as the active pharmaceutical ingredients, raw materials, chemicals, other inputs and intermediaries, and specialty equipment used to invent, manufacture, and deploy these products.

Click through the IC slide show.

 

View Project

WHO: ACT-Accelerator partnership

Global leaders attending the US-hosted Global COVID-19 Summit on 22 September re-affirmed their commitment to ending the acute phase of the pandemic, and the goals of the ACT-Accelerator, by agreeing targets to provide equitable access to COVID-19 tests, treatments, and vaccines.

Global targets agreed at the Summit include vaccinating 40% of the world’s population in 2021 and 70% of the population in 2022; achieving testing rates of one per 1,000 people per day in all countries by the end of 2021; and for all facilities treating patients with severe COVID-19 to have sufficient oxygen supplies, quality-assured treatments and PPE.

Read the full story.

View Project

UN: Covid-19 Summit: Sharing Knowledge, Technology Critical to Curb Virus

Leaders at a virtual Covid-19 summit on the sidelines of the United Nations General Assembly on September 22, 2021, pledged to mobilize millions of doses of Covid-19 vaccines and billions of dollars to “build back better”. Following the summit, the US and European Commission made public a statement to launch a “taskforce” on Covid-19 manufacturing and supply chains, which includes a commitment to coordinate initiatives to boost global production of vaccines and therapeutics.

Read the full story.

View Project

COVID-19 Strategic Preparedness and Response Plan (SPRP 2021)

WHO is issuing the COVID-19 Strategic Preparedness and Response Plan (SPRP) for 2021 and accompanying documents as a package aimed at guiding the coordinated action that we must take at national, regional, and global levels to overcome the ongoing challenges in the response to COVID-19, address inequities, and plot a course out of the pandemic.

The Strategic Preparedness and Response Plan 2021 (SPRP2021) builds on what has been learned about the virus and our collective response over the course of 2020, and translates that knowledge into strategic actions. This plan builds on achievements and also focuses on the new challenges, to mitigate, for example, risks related to new variants. The plan also considers the road we need to travel towards the safe, equitable and effective delivery of diagnostics and vaccines as part of the overall strategy to successfully tackle the COVID-19 pandemic.

Read the full story.

View Project

South Korea launches task force on vaccine and lays out new approach to trade

With the launch of a task force on vaccine production South Korea aims to become the world’s fifth-largest vaccine-producing nation in the next four years. President Moon Jae-in said South Korea aims to become the world’s fifth-largest vaccine-producing nation in the next four years. Moon has pledged to designate vaccine development as one of the nation’s three strategic technology areas, along with those of semiconductors and batteries, and invest 2.2 trillion won (US$1.92 billion) in the next five years (read the full story here).

Furthermore, according to Trade Minister Yeo Han-koo, South Korea will present a new concept for trade in five important sectors, including pharmaceuticals. Korea will provide the necessary support to companies producing vaccines to enter the global vaccine supply and establish bases in countries where major vaccine producers are located. The country will seek to reduce tariffs on vaccines through partnership with World Trade Organisation member countries (read the full story here).

View Project

Q&A with TechInvention

Innovation Council brings together diverse innovators to share their experiences with policymakers and other stakeholders. TechInvention Lifecare PvT Ltd, was founded in 2016 with the objective of increasing the supply of Vaccines and Bio-Therapeutics for low and middle-income countries (LMICs), is an Innovation Council member based in India. Here, in his own words, Syed Ahmed, the company’s CEO, shares insights about his company’s activities, challenges, and successes in recent years.

Read the full story.

View Project

OECD Economic Outlook, Interim Report: Keeping the Recovery on Track

The Organization for Economic Cooperation and Development (O.E.C.D.) published its Economic Outlook Interim Report stating that a global economic recovery from the pandemic was finally taking hold, but it inched back its forecast for worldwide economic growth and warned that the rebound was benefiting wealthier countries more than the developing world as vaccine distribution occurs at an uneven pace. Countries that have made big strides toward vaccinating most of their populations are bouncing back much more quickly than those that are still struggling to obtain shots, the O.E.C.D. said, raising a host of related economic problems that are affecting global supply chains and pose a risk for the future.

Laurence Boone, the organization’s chief economist: “If we continue to vaccinate and adapt better to living with the virus, supply will begin to normalize and this pressure will fade, but for that we have to vaccinate more people.”

Read the full story.

View Project